Statements (32)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:approves |
gptkb:1995
gptkb:FDA |
| gptkbp:brand |
Microgestin 1.5/30
Microgestin 1/20 Microgestin Fe |
| gptkbp:contains |
gptkb:norethindrone
gptkb:ethinyl_estradiol |
| gptkbp:contraindication |
liver disease
history of blood clots smoking over age 35 |
| gptkbp:dosage_form |
21-day regimen
28-day regimen |
| gptkbp:formulation |
oral tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Microgestin
|
| gptkbp:ingredients |
gptkb:norethindrone_acetate
gptkb:ethinyl_estradiol |
| gptkbp:interacts_with |
gptkb:St._John's_Wort
antibiotics anticonvulsants |
| gptkbp:is_available_in |
generic form
|
| gptkbp:is_used_for |
contraception
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:packaging |
blister pack
|
| gptkbp:requires |
gptkb:theorem
|
| gptkbp:side_effect |
headache
nausea weight gain breast tenderness |
| gptkbp:storage |
room temperature
|
| gptkbp:bfsParent |
gptkb:ethinylestradiol
|
| gptkbp:bfsLayer |
6
|